Wegovy and Hypothyroidism: Safety, Suitability and What the Evidence Says

Step 1: Understand the thyroid contraindication that applies to everyone on semaglutide

Before any discussion of hypothyroidism specifically, one point applies universally: semaglutide is contraindicated in people with a personal or family history of medullary thyroid carcinoma, or in those with MEN2 syndrome. This is not a theoretical caution, it is listed in the Mounjaro and Wegovy SmPCs on the eMC as an absolute contraindication, reflecting findings from rodent studies in which GLP-1 receptor agonists were associated with thyroid C-cell tumours. Those findings have not been replicated in human trials, but the signal is taken seriously enough that the contraindication stands across all GLP-1 medicines currently licensed in the UK.

If your thyroid condition is autoimmune hypothyroidism (Hashimoto's thyroiditis) or a non-cancerous underactive thyroid, that specific contraindication does not apply to you. You still need a prescriber to review your full history, but your diagnosis alone does not close the door. The question of suitability with an underactive thyroid turns on different factors, which the next steps cover.

Worth checking: if you have ever been told you have thyroid nodules or a family member has had thyroid cancer, raise that explicitly in your consultation, it affects the risk assessment even if your own biopsy was benign. If you have an overactive thyroid rather than an underactive one, our page covering hyperthyroidism and Wegovy addresses the specific considerations that apply in that situation.

Step 2: Know how semaglutide may affect levothyroxine absorption

Levothyroxine is one of the most absorption-sensitive medicines in common use. It is typically taken first thing in the morning on an empty stomach precisely because food, coffee and many other medicines can reduce how much of it reaches the bloodstream. Semaglutide slows gastric emptying (that is part of how it reduces appetite) and slower gastric emptying can, in principle, alter the rate at which levothyroxine is absorbed, even if the total amount absorbed remains broadly similar over time.

The clinical evidence on this specific interaction is limited. There are no large randomised trials examining levothyroxine levels in hypothyroid patients taking semaglutide. What clinicians generally advise is practical: keep taking levothyroxine at its usual time and in the usual way, tell your GP you are starting semaglutide, and arrange thyroid function tests (TSH, free T4) a few weeks after beginning treatment or after each dose increase. NHS guidance on semaglutide recommends informing all your healthcare providers about any new prescription medicine.

Significant changes in your weight (the kind that semaglutide can produce) can themselves alter thyroid hormone requirements. Some people find their levothyroxine dose needs adjusting as they lose weight; this is not unique to GLP-1 treatment, but it is a reason to keep your GP in the loop throughout.

Step 3: Work out what a safe prescribing pathway looks like for you

If your hypothyroidism is well controlled on a stable levothyroxine dose and your most recent thyroid function tests were normal, a prescriber reviewing your case for Wegovy will want to confirm that stability. That is not a barrier, it is standard clinical due diligence. Our clinical team at nume reviews every case personally; a recent TSH result and your current prescription are the kinds of evidence that support a clear, safe decision.

If your thyroid function has been fluctuating recently, or if your dose has changed in the past few months, a prescriber is likely to want that resolved before starting a new treatment that could further affect absorption. The right person to coordinate that conversation is your GP or endocrinologist, not the weight-loss service alone.

People who are pregnant, trying to conceive, or breastfeeding should not take Wegovy, this applies irrespective of thyroid status. If weight management during or after pregnancy is a concern, that requires specialist advice; our page on Wegovy and pregnancy explains this in more detail.

Step 4: How to approach treatment through a regulated service

If you decide to explore Wegovy through a private route, the process at a properly regulated online pharmacy is straightforward. At nume, you complete a free clinical consultation; a GPhC-registered Independent Prescriber reads your answers the same day, your thyroid history, current medication list and recent blood results all form part of that review. If treatment is approved, you can read more about how Wegovy is delivered to your door, dispatched the same day for free next-working-day delivery via DPD, arriving in plain, unbranded packaging with a tracking notification on your phone.

For people managing a thyroid condition, the aftercare piece matters as much as the initial approval. You can reach our prescribers seven days a week if your symptoms change after starting, and we ask every patient to keep their GP informed, not as a formality, but because levothyroxine monitoring genuinely benefits from someone who knows your longer thyroid history. If you want to understand the full Wegovy treatment journey before deciding, that is a sensible place to start. When you are ready, start your free consultation and our team will take it from there.

You can verify that any online pharmacy dispensing prescription medicines is properly registered by checking the GPhC pharmacy register, a quick step that the MHRA consistently recommends when buying medicines online.